Inventor
SPERINDE JEFF
US11 patents
⚠️ This page may combine multiple inventors who share the name “SPERINDE JEFF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LABORATORY CORP AMERICA HOLDINGS
5 patentsUS9766242B2Sep 19, 2017
Methods of determining patient response by measurement of HER-3 and P95
LABORATORY CORP AMERICA HOLDINGS3 citations71
US10775382B2Sep 15, 2020
Methods of determining patient response by measurement of HER-3
LABORATORY CORP AMERICA HOLDINGS0 citations50
US11401344B2Aug 2, 2022
Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients
LABORATORY CORP AMERICA HOLDINGS0 citations49
US10273308B2Apr 30, 2019
Methods of producing antibodies specific for p95
LABORATORY CORP AMERICA HOLDINGS0 citations49
US11579148B2Feb 14, 2023
Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients
LABORATORY CORP AMERICA HOLDINGS0 citations48
LAB CORP AMERICA HOLDINGS
4 patentsUS8349574B2Jan 8, 2013
Methods of determining patient response by measurement of Her-3
LAB CORP AMERICA HOLDINGS42 citations95
US9110066B2Aug 18, 2015
HER-3 antibodies and methods of use
LAB CORP AMERICA HOLDINGS4 citations82
US7939267B2May 10, 2011
Detection of activation of endothelial cells as surrogate marker for angiogenesis
LAB CORP AMERICA HOLDINGS18 citations78
US9081019B2Jul 14, 2015
Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95
LAB CORP AMERICA HOLDINGS3 citations59